Reduced oxazolone-induced skin inflammation in MAPKAP kinase 2 knockout mice

Journal of Investigative Dermatology

Volumn 129, Issue 4, 2009, Pages 891-898

  Funding, Anne T ^a   Johansen, Claus ^a   Gaestel, Matthias ^b   Bibby, Bo M ^c   Lilleholt, Louise L ^a   Kragballe, Knud ^a   Iversen, Lars ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; GAMMA INTERFERON; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE ACTIVATED PROTEIN KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELOPEROXIDASE; OXAZOLONE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SKIN ALLERGY; SKIN BIOPSY; SKIN INFLAMMATION;

ANIMALS; DERMATITIS, ALLERGIC CONTACT; IMIDAZOLES; INTERFERON-GAMMA; INTERLEUKIN-1BETA; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OXAZOLONE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; PYRIDINES; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 63149088840     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2008.322     Document Type: Article

References (32)

1. Arthur JS, Darragh J (2006) Signaling downstream of p38 in psoriasis. J Invest Dermatol 126:1689-91
2. Bachelor MA, Cooper SJ, Sikorski ET, Bowden GT (2005) Inhibition of p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase decreases UVB-induced activator protein-1 and cyclooxygenase-2 in a SKH-1 hairless mouse model. Mol Cancer Res 3:90-9
3. Beardmore VA, Hinton HJ, Eftychi C, Apostolaki M, Armaka M, Darragh J et al. (2005) Generation and characterization of p38beta (MAPK11) gene-targeted mice. Mol Cell Biol 25:10454-64
4. Bos JD, de Rie MA, Teunissen MBM, Piskin G (2005) Psoriasis dysregulation of innate immunity. Br J Dermatol 152:1098-107
5. Campbell J, Ciesielski CJ, Hunt AE, Horwood NJ, Beech JT, Hayes LA et al. (2004) A novel mechanism for TNF-alpha regulation by p38 MAPK: involvement of NF-kappa B with implications for therapy in rheumatoid arthritis. J Immunol 173:6928-37
6. Dearman RJ, Ramdin LSP, Basketter DA, Kimber I (1994) Inducible interleukin-4-secreting cells provoked in mice during chemical sensitization. Immunology 81:551-7
7. Enk AH, Katz SI (1995) Contact sensitivity as a model for T-cell activation in skin. J Invest Dermatol 105:S80-3
8. Gaestel M (2006) MAPKAP kinases-MKs-two's company, three's a crowd. Nat Rev Mol Cell Biol 7:120-30
9. Goebeler M, Gillitzer R, Kilian K, Utzel K, Brocker EB, Rapp UR et al. (2001) Multiple signaling pathways regulate NF-kappa B-dependent transcription of the monocyte chemoattractant protein-1 gene in primary endothelial cells. Blood 97:46-55
10. Gudjonsson JE, Johnston A, Dyson M, Valdimarsson H, Elder JT (2007) Mouse models of psoriasis. J Invest Dermatol 127:1292-308
11. Hegen M, Gaestel M, Nickerson-Nutter CL, Lin LL, Telliez JB (2006) MAPKAP kinase 2-deficient mice are resistant to collagen-induced arthritis. J Immunol 177:1913-7
12. Hildesheim J, Awwad RT, Fornace AJ (2004) p38 mitogen-activated protein kinase inhibitor protects the epidermis against the acute damaging effects of ultraviolet irradiation by blocking apoptosis and inflammatory responses. J Invest Dermatol 122:497-502
13. Johansen C, Funding AT, Otkjaer K, Kragballe K, Jensen UB, Madsen M et al. (2006) Protein expression of TNF-alpha in psoriatic skin is regulated at a posttranscriptional level by MAPK-activated protein kinase 2. J Immunol 176:1431-8
14. Johansen C, Kragballe K, Westergaard M, Henningsen J, Kristiansen K, Iversen L (2005) The mitogen-activated protein kinases p38 and ERK1/2 are increased in lesional psoriatic skin. Br J Dermatol 152:37-42
15. Kim AL, Labasi JM, Zhu YC, Tang XW, McClure K, Gabel CA et al. (2005) Role of p38 MAPK in UVB-induced inflammatory responses in the skin of SKH-1 hairless mice. J Invest Dermatol 124:1318-25
16. Kimber I, Cumberbatch M, Dearman RJ, Bhushnan M, Griffiths CEM (2000) Cytokines and chemokines in the initiation and regulation of epidermal Langerhans cell mobilization. Br J Dermatol 142:401-12
17. Kotlyarov A, Neininger A, Schubert C, Eckert R, Birchmeier C, Volk HD et al. (1999) MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis. Nat Cell Biol 1:94-7
18. Kotlyarov A, Yannoni Y, Fritz S, Laass K, Telliez JB, Pitman D et al. (2002) Distinct cellular functions of MK2. Mol Cell Biol 22:4827-35
19. Krueger G, Ellis CN (2005) Psoriasis-recent advances in understanding its pathogenesis and treatment. J Am Acad Dermatol 53:S94-100
20. Neininger A, Kontoyiannis D, Kotlyarov A, Winzen R, Eckert R, Volk HD et al. (2002) MK2 targets AU-rich elements and regulates biosynthesis of tumor necrosis factor and interleukin-6 independently at different posttranscriptional levels. J Biol Chem 277:3065-8
21. Nickoloff BJ, Kunkel SL, Burdick M, Strieter RM (1995) Severe combined immunodeficiency mouse and human psoriatic skin chimeras-validation of a new animal-model. Am J Pathol 146:580-8
22. Ono K, Han JH (2000) The p38 signal transduction pathway-activation and function. Cell Signal 12:1-13
23. Ottosen ER, Sorensen MD, Bjorkling F, Skak-Nielsen T, Fjording MS, Aaes H et al. (2003) Synthesis and structure-activity relationship of aminobenzophenones. A novel class of p38 MAP kinase inhibitors with high antiinflammatory activity. J Med Chem 46:5651-62
24. Petersen TK (2006) In vivo pharmacological disease models for psoriasis and atopic dermatitis in drug discovery. Basic Clin Pharmacol/Toxicol 99:104-15
25. Romagnani S (1997) The Th1/Th2 paradigm. Immunol Today 18:263-6
26. Roux PP, Blenis J (2004) ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev 68:320-44
27. Takanami-Ohnishi Y, Amano S, Kimura S, Asada S, Utani A, Maruyama M et al. (2002) Essential role of p38 mitogen-activated protein kinase in contact hypersensitivity. J Biol Chem 277:37896-903
28. Tortarolo M, Veglianese P, Calvaresi N, Botturi A, Rossi C, Giorgini A et al. (2003) Persistent activation of p38 mitogen-activated protein kinase in a mouse model of familial amyrotrophic lateral sclerosis correlates with disease progression. Mol Cell Neurosci 23:180-92
29. Webb EF, Tzimas MN, Newsholme SJ, Griswold DE (1998) Intralesional cytokines in chronic oxazolone-induced contact sensitivity suggest roles for tumor necrosis factor alpha and interleukin-4. J Invest Dermatol 111:86-92
30. Westphal GA, Schnuch A, Moessner R, Konig IR, Kranke B, Hallier E et al. (2003) Cytokine gene polymorphisms in allergic contact dermatitis. Contact Dermat 48:93-8
31. Westra J, Limburg PC (2006) P38 mitogen-activated protein kinase (MAPK) in rheumatoid arthritis. Mini Rev Med Chem 6:867-74
32. Yanagi T, Kodama K, Yoshihisa Y, Shimizu H, Shimizu T (2006) Macrophage migration inhibitory factor in zinc-allergic systemic contact dermatitis. Cytokine 35:270-4